Oral Cancer Screening: Application of Vital Stains as Adjuncts to Clinical Examination

An essential first line of investigation in oral oncology is clinical examination of high-risk oral sites. Given the elevated DNA content in cancers, vital dyes such as toluidine blue, methylene blue, Lugol’s iodine, and rose bengal, which have an inherent chemical capacity to bind to DNA, have been studied for their clinical utility in screening malignant changes in the oral cavity. In this chapter, we cover the basics of clinical examination and review the literature on the use of vital stains as adjunct diagnostic aids in patients with clinically suspicious oral lesions such as leukoplakia and erythroplakia. The goal of this chapter is to provide the reader with an overview of the vital stains available on the market and their potential for clinical application. A discussion of their strengths, limitations, and the rationale for development of new screening methods, has also been provided.

[1]  R. Richart A clinical staining test for the in vivo delineation of dysplasia and carcinoma in situ. , 1963, American Journal of Obstetrics and Gynecology.

[2]  A. Mashberg Reevaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma: A continuing prospective study of oral cancer III , 1980, Cancer.

[3]  C Scully,et al.  Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. , 1992, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[4]  Rose bengal staining for clinical detection of oral premalignant lesions and carcinomas , 1992 .

[5]  M. Nair,et al.  Evaluation of mouth self-examination in the control of oral cancer. , 1995, British Journal of Cancer.

[6]  N. Johnson,et al.  Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer. , 1996, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[7]  N. Powe,et al.  Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. , 2000, Gastrointestinal endoscopy.

[8]  P. Pisani,et al.  Early findings from a community‐based, cluster‐randomized, controlled oral cancer screening trial in Kerala, India , 2000, Cancer.

[9]  J. Kusukawa,et al.  Dissemination of cancer cells into circulation occurs by incisional biopsy of oral squamous cell carcinoma. , 2000, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[10]  D. Parkin,et al.  Interim results from a cluster randomized controlled oral cancer screening trial in Kerala, India. , 2003, Oral oncology.

[11]  R. Rohs,et al.  Methylene Blue Binding to DNA with Alternating AT Base Sequence: Minor Groove Binding is Favored over Intercalation , 2004, Journal of biomolecular structure & dynamics.

[12]  Stephen Palmer,et al.  A systematic review of test performance in screening for oral cancer and precancer. , 2004, Oral oncology.

[13]  Nhu D Le,et al.  Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. , 2005, Cancer research.

[14]  G. Thomas,et al.  Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial , 2005, The Lancet.

[15]  J. Terdiman,et al.  Acute toxic gastric mucosal damage induced by Lugol’s iodine spray during chromoendoscopy , 2005, Gut.

[16]  C. Scully,et al.  Toluidine blue uptake in potentially malignant oral lesions in vivo: clinical and histological assessment. , 2006, Oral oncology.

[17]  Ya-Wei Chen,et al.  Use of methylene blue as a diagnostic aid in early detection of oral cancer and precancerous lesions. , 2007, The British journal of oral & maxillofacial surgery.

[18]  Myung-Gyu Choi,et al.  Acute esophageal and gastric injury: Complication of Lugol's solution , 2007, Scandinavian journal of gastroenterology.

[19]  S. Kao,et al.  Application of In Vivo Stain of Methylene Blue as a Diagnostic Aid in the Early Detection and Screening of Oral Squamous Cell Carcinoma and Precancer Lesions , 2007, Journal of the Chinese Medical Association : JCMA.

[20]  Z. Cao,et al.  Rose bengal staining in detection of oral precancerous and malignant lesions with colorimetric evaluation: A pilot study , 2007, International journal of cancer.

[21]  A. Akobeng,et al.  Understanding diagnostic tests 3: receiver operating characteristic curves , 2007, Acta paediatrica.

[22]  L. Patton,et al.  Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. , 2008, Journal of the American Dental Association.

[23]  P. Speight,et al.  Critical Evaluation of Diagnostic Aids for the Detection of Oral Cancer , 2008 .

[24]  S. Subramanian,et al.  Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India. , 2009, Bulletin of the World Health Organization.

[25]  S. Fedele Diagnostic aids in the screening of oral cancer , 2009, Head & neck oncology.

[26]  Jianmin Wu,et al.  Interaction Between Methylene Blue and CalfThymus Deoxyribonucleic Acid by Spectroscopic Technologies , 2009, Journal of Fluorescence.

[27]  N. Lombardo,et al.  The usefulness of toluidine staining as a diagnostic tool for precancerous and cancerous oropharyngeal and oral cavity lesions. , 2009, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[28]  S. Warnakulasuriya Global epidemiology of oral and oropharyngeal cancer. , 2009, Oral oncology.

[29]  R. Ramaraj,et al.  Binding Interactions of Toluidine Blue O with Escherichia Coli DNA: Formation of Bridged Structure , 2011, Journal of Fluorescence.

[30]  T. Takata,et al.  Histopathological evaluation including cytokeratin 13 and Ki-67 in the border between Lugol-stained and -unstained areas. , 2010, Oncology reports.

[31]  Massimo Petruzzi,et al.  Use of Lugol's iodine in oral cancer diagnosis: an overview. , 2010, Oral oncology.

[32]  Rutao Liu,et al.  Investigation on the toxic interaction of toluidine blue with calf thymus DNA. , 2010, Journal of hazardous materials.

[33]  L. Ashok,et al.  Diagnostic efficiency of toluidine blue with Lugol's iodine in oral premalignant and malignant lesions. , 2010, Indian journal of dental research : official publication of Indian Society for Dental Research.

[34]  D. Richards Does toluidine blue detect more oral cancer? , 2010, Evidence-Based Dentistry.

[35]  A. Glenny,et al.  Screening programmes for the early detection and prevention of oral cancer. , 2013, Cochrane Database of Systematic Reviews.

[36]  S. Chiu,et al.  A Community-based RCT for Oral Cancer Screening with Toluidine Blue , 2010, Journal of dental research.

[37]  A. Suresh,et al.  Mouth self-examination to improve oral cancer awareness and early detection in a high-risk population. , 2011, Oral oncology.

[38]  Chi V. Dang,et al.  Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.

[39]  Guiyong Peng,et al.  Evaluation of double vital staining with lugol's iodine and methylene blue in diagnosing superficial esophageal lesions , 2011, Scandinavian journal of gastroenterology.

[40]  S. Palaskar,et al.  Rose Bengal staining - diagnostic aid for potentially malignant and malignant disorders: a pilot study. , 2012, Indian journal of dental research : official publication of Indian Society for Dental Research.

[41]  G. Sridharan,et al.  Toluidine blue: A review of its chemistry and clinical utility , 2012, Journal of oral and maxillofacial pathology : JOMFP.

[42]  G. Thomas,et al.  Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India. , 2013, Oral oncology.

[43]  G. Suresh Kumar,et al.  Spectroscopic studies on the binding interaction of phenothiazinium dyes toluidine blue O, azure A and azure B to DNA. , 2013, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[44]  M. Kamboj,et al.  Methylene blue as an early diagnostic marker for oral precancer and cancer , 2013, SpringerPlus.

[45]  L. González,et al.  Molecular dynamics simulations of binding modes between methylene blue and DNA with alternating GC and AT sequences. , 2014, Biochemistry.

[46]  R. Zain,et al.  Oral Cancer and Oral Potentially Malignant Disorders , 2014, International journal of dentistry.

[47]  R. Shukla,et al.  Utility of Toluidine Blue Test in Accessing and Detecting Intra-Oral Malignancies , 2015, Indian Journal of Otolaryngology and Head & Neck Surgery.

[48]  E. Omar Current concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma - a systematic review , 2015, Head & Face Medicine.

[49]  R. Arpita,et al.  Methylene Blue as a Diagnostic Aid in the Early Detection of Potentially Malignant and Malignant Lesions of Oral Mucosa , 2016, Ethiopian journal of health sciences.

[50]  Methylene blue staining in the parotid surgery: Randomized trial, 144 patients. , 2016, American journal of otolaryngology.

[51]  Alonso Carrasco-Labra,et al.  Adjuncts for the evaluation of potentially malignant disorders in the oral cavity: Diagnostic test accuracy systematic review and meta-analysis-a report of the American Dental Association. , 2017, Journal of the American Dental Association.

[52]  Jacques Ferlay,et al.  The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012 , 2017, CA: a cancer journal for clinicians.